Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.42 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.38 |
| ▸ | DHFR | P00374 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17636713 | 0.96 | MAPT (0.40) | MAPTMDM2KMT2A | |
| SCHEMBL17636669 | 0.94 | MAPT (0.42) | MAPTDHFRALDH1A1L3MBTL1 | |
| SCHEMBL17636653 | 0.92 | MAPT (0.42) | MAPTMDM2ALDH1A1L3MBTL1KMT2A | |
| SCHEMBL17636650 | 0.91 | MAPT (0.43) | MAPTDHFRALDH1A1L3MBTL1 | |
| SCHEMBL17636680 | 0.90 | MAPT (0.40) | MAPT | |
| SCHEMBL18538760 | 0.88 | MDM2 (0.44) | MDM2ALDH1A1L3MBTL1KMT2A | |
| SCHEMBL17636645 | 0.87 | KDM4E (0.41) | ALDH1A1L3MBTL1KMT2A | |
| SCHEMBL17636631 | 0.87 | MAPT (0.44) | MAPTALDH1A1L3MBTL1KMT2A | |
| SCHEMBL17636678 | 0.86 | MAPT (0.43) | MAPTDHFRALDH1A1L3MBTL1 | |
| SCHEMBL17636689 | 0.86 | MAPT (0.41) | MAPTDHFRALDH1A1L3MBTL1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9960365-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2018-05-01 | — | — | US | disclosed |
| US-9960365-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2018-05-01 | — | — | US | disclosed |
| US-20160093811-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-03-31 | — | — | US | disclosed |
| US-20160093811-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160093811-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CCNT1, CCNA1 | MAPT 1845/4885MDM2 3191/4885DHFR 3320/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.